School of Medicine


Showing 1-50 of 149 Results

  • Kimberly Allison

    Kimberly Allison

    Professor of Pathology at the Stanford University Medical Center

    Current Research and Scholarly Interests Dr. Allison’s clinical expertise is in breast pathology. Her research interests include how standards should be applied to breast cancer diagnostics (such as ER and HER2 testing), the utility of molecular panel-based testing in breast cancer, digital pathology applications and identifying the most appropriate management of specific pathologic diagnoses.

  • Euan A. Ashley

    Euan A. Ashley

    Associate Dean, School of Medicine, Professor of Medicine (Cardiovascular), of Genetics, of Biomedical Data Science and, by courtesy, of Pathology at the Stanford University Medical Center

    Current Research and Scholarly Interests The Ashley lab is focused on precision medicine. We develop methods for the interpretation of whole genome sequencing data to improve the diagnosis of genetic disease and to personalize the practice of medicine. At the wet bench, we take advantage of cell systems, transgenic models and microsurgical models of disease to prove causality in biological pathways and find targets for therapeutic development.

  • Susan Atwater

    Susan Atwater

    Clinical Associate Professor, Pathology

    Current Research and Scholarly Interests I am interested in optimizing the process of diagnosing leukemias, lymphomas and other hematolymphoid neoplasms, particularly by the use of diagnostic flow cytometry. One goal is to develop flow data analysis processes that function as interactive tools, allowing pathologists to query rich diagnostic data sets in real time.

  • Jeffrey Axelrod

    Jeffrey Axelrod

    Professor of Pathology

    Current Research and Scholarly Interests Genetic and cell biological analyses of signals controlling cell polarity and morphogenesis. Frizzled signaling and cytoskeletal organization.

  • Steven Andrew Baker

    Steven Andrew Baker

    Clinical Instructor, Pathology

    Bio Dr. Steven Baker is a clinical instructor in the Department of Pathology. He graduated from Cornell University with a B.S. in Biological Sciences before completing an M.D. and Ph.D., in Developmental Biology, at Baylor College of Medicine. Clinically he specializes in the laboratory analysis of hemostatic disorders.

  • Niaz Banaei

    Niaz Banaei

    Professor of Pathology and of Medicine (Infectious Diseases) at the Stanford University Medical Center

    Current Research and Scholarly Interests His research interests include (1) development, assessment, and improvement of novel infectious diseases diagnostics, (2) enhancing the quality of C. difficile diagnostic results, and (3) characterization of M. tuberculosis virulence determinants.

  • Ellen Jo Baron

    Ellen Jo Baron

    Professor of Pathology at the Stanford University Medical Center, Emerita

    Current Research and Scholarly Interests No current scientific activities. I am retired.

  • Dr. Gregory Bean

    Dr. Gregory Bean

    Assistant Professor of Pathology at the Stanford University Medical Center

    Bio Dr. Bean is an Assistant Professor who specializes in breast pathology. His research interests include molecular characterization of breast cancer subtypes and precursors. He is also involved with the training of residents and fellows on the breast service.

  • Sean Bendall

    Sean Bendall

    Assistant Professor (Research) of Pathology

    Current Research and Scholarly Interests Our goal is to understand the mechanisms regulating the development of human systems. Drawing on both pluripotent stem cell biology, hematopoiesis, and immunology, combined with novel high-content single-cell analysis (CyTOF ? Mass Cytometry) and imagining (MIBI-Multiplexed Ion Beam Imaging) we are creating templates of ?normal? human cellular behavior to both discover novel regulatory events and cell populations as well as understand dysfunctional processes such as cancer.

  • Gerald Berry

    Gerald Berry

    Professor of Pathology at the Stanford University Medical Center

    Current Research and Scholarly Interests Cardiopulmonary and pulmonary transplant medicine; diagnostic surgical pathology

  • David Bingham

    David Bingham

    Clinical Assistant Professor, Pathology

    Bio David Bingham MD is a clinical assistant pathologist specializing in gastrointestinal pathology. He is from Connecticut, graduated from Yale with a BA, and went to Columbia P&S for medical school. He did a residency in Pathology at Stanford University, graduated in 1992 and has been here ever since as a faculty member.

  • Matthew Bogyo

    Matthew Bogyo

    Professor of Pathology and of Microbiology and Immunology and, by courtesy, of Chemical and Systems Biology

    Current Research and Scholarly Interests Our lab uses chemical, biochemical, and cell biological methods to study protease function in human disease. Projects include:

    1) Design and synthesis of novel chemical probes for serine and cysteine hydrolases.

    2) Understanding the role of hydrolases in bacterial pathogenesis and the human parasites, Plasmodium falciparum and Toxoplasma gondii.

    3) Defining the specific functional roles of proteases during the process of tumorogenesis.

    4) In vivo imaging of protease activity

  • Donald Born

    Donald Born

    Clinical Professor, Pathology

    Bio Dr. Born obtained his medical degree from the University of Virginia where he also completed a Ph.D. in Neuroscience. His next training occurred at the University of Washington as an Anatomic Pathology resident and Neuropathology fellow. He moved to Stanford in 2013 and as Clinical Professor of Pathology he sees a wide range of samples related to the field of neuropathology.

  • Scott Boyd, MD PhD

    Scott Boyd, MD PhD

    Associate Professor of Pathology

    Current Research and Scholarly Interests Our goal is to understand the lymphocyte genotype-phenotype relationships in healthy human immunity and in immunological diseases. We apply new technologies and data analysis approaches to this challenge, particularly high-throughput DNA sequencing and single-cell monoclonal antibody generation, in parallel with other functional assays.

  • Ryanne Ashley Brown, MD, MBA

    Ryanne Ashley Brown, MD, MBA

    Clinical Assistant Professor, Pathology

    Bio Ryanne Brown, M.D., M.B.A., is a Clinical Assistant Professor of Pathology and (by courtesy) Dermatology. She completed her residency training in Anatomic and Clinical Pathology followed by Surgical Pathology and Dermatopathology fellowships at Stanford. She is board certified in both Anatomic Pathology and Clinical Pathology (American Board of Pathology) and Dermatopathology (American Boards of Pathology/Dermatology). Her interests include cutaneous lymphoma and histiocytic neoplasms.

  • Jillian Buchan

    Jillian Buchan

    Clinical Assistant Professor, Pathology

    Bio Jillian is a board-certified Clinical Molecular Geneticist working in Stanford Medicine?s Clinical Genomics Program (CGP). She completed a research-based MS at University College Dublin in Ireland and later received her PhD in Molecular Genetics and Genomics in 2014 from Washington University in St. Louis. After her PhD, Jillian joined Harvard Medical School's Genetics Training Program and completed her fellowship in Clinical Molecular Genetics in 2016. Jillian then joined the Department of Pathology at Stanford School of Medicine and became board-certified by the American Board of Medical Genetics and Genomics in 2017. Her focus is on molecular-based diagnostic testing, with the majority of her time spent in the CGP, where she oversees overall laboratory operations, development of new next-generation sequencing-based clinical assays, ensures CAP/CLIA regulatory compliance, and signs out clinical test reports. She and her team launched Stanford's first clinical exome sequencing test, and the first test for the newly created CGP, in early 2018.

  • Eugene Butcher

    Eugene Butcher

    Klaus Bensch Professor in Pathology

    Current Research and Scholarly Interests Our interests include:
    1) The physiology and function of lymphocyte homing in local and systemic immunity;
    2) Biochemical and genetic studies of molecules that direct leukocyte recruitment;
    3) Chemotactic mechanisms and receptors in vascular and immune biology;
    4) Vascular control of normal and pathologic inflammation and immunity;
    5) Systems biology of immune cell trafficking and programming in tumor immunity.

  • Greg Charville, MD, PhD

    Greg Charville, MD, PhD

    Assistant Professor of Pathology at the Stanford University Medical Center

    Bio As Assistant Professor of Pathology at Stanford University School of Medicine, Dr. Charville has a special interest in the diagnosis of rare tumors that derive from bone and soft tissues, including muscle, fat, blood vessels, cartilage, and other connective tissues. He also specializes in the classification and study of disorders related to the gastrointestinal and hepatopancreatobiliary systems.

    Dr. Charville particularly enjoys working alongside Stanford's excellent physicians-in-training to classify the most diagnostically challenging cases in collaboration with pathologists from around the world, bringing to bear cutting-edge techniques for comprehensive histologic and molecular characterization in each case. This experience serves as the inspiration for laboratory-based investigation of the molecular basis of human disease, focusing on genetic and epigenetic mechanisms of neoplasia.

  • Athena Cherry

    Athena Cherry

    Professor of Pathology and of Pediatrics at the Stanford University Medical Center and the Lucile Salter Packard Children's Hospital

    Current Research and Scholarly Interests The use of molecular and molecular cytogenetic methods to identify chromosomal abnormalities in acquired and congenital disorders.

  • Michael Cleary

    Michael Cleary

    Lindhard Family Professor in Pediatric Cancer Biology and Professor of Pathology

    Current Research and Scholarly Interests The role of oncoproteins in cancer and development; molecular and cellular biology of hematologic malignancies; targeted molecular therapies of cancer.

  • Maria Inmaculada Cobos Sillero

    Maria Inmaculada Cobos Sillero

    Assistant Professor of Pathology at the Stanford University Medical Center

    Current Research and Scholarly Interests Our lab uses cellular and molecular methods, single-cell technology, and quantitative histology to study human neurodegenerative diseases. Current projects include:

    - Using single-cell RNA-sequencing to understand selective vulnerability and disease progression in human Alzheimer?s disease brain

    - Investigating mechanisms of tau-related neurodegeneration in human brain

    - Studying the neocortical and limbic systems in Diffuse Lewy Body Disease (DLBD) at the single cell level

  • Le Cong

    Le Cong

    Assistant Professor of Pathology (Pathology Research) and of Genetics

    Bio Dr. Cong is leading a group in the Department of Pathology and Genetics at Stanford School of Medicine to pursue novel technology for scalable genome editing and single-cell genomics, and accompanying computational approaches inspired by data science. His group has a focus on studying immunology in the context of cancer and neuroscience.

    He obtained his BS with highest honor from Tsinghua University studying Electronic Engineering and then Biology, his Ph.D. from Harvard Medical School co-advised by Drs. Feng Zhang and George Church. He completed doctoral work primarily in Dr. Feng Zhang?s laboratory, where he published seminal studies on harnessing CRISPR/Cas9 for gene editing, including the most highly-cited paper in CRISPR field, with cumulative citation over 15,000 times. He has obtained over 20 issued patents as co-inventor, and his work led to one of the first FDA-approved clinical trials employing viral delivery of CRISPR/Cas9 for in vivo gene therapy. His later work applied single-cell RNA-seq to cancer drug discovery under Dr. Aviv Regev at the Broad Institute with Drs. Tyler Jacks and Vijay Kuchroo.

    Dr. Cong was a Howard Hughes Medical Institute (HHMI) International Fellow, a Cancer Research Institute (CRI) Irvington Fellow, and was selected as Forbes 30 Under 30 Asia list of young innovators, MIT TechReview TR35 China, and 2019 ?Top 10 under 40? by GEN (Genetic Engineering & Biotechnology News).

  • M. Ryan Corces

    M. Ryan Corces

    Instructor, Pathology

    Bio Dr. Corces is an instructor at Stanford University in the department of Pathology. He graduated from Princeton University in 2008 with a degree in molecular biology. He began his PhD in cancer biology at Stanford University in 2009, focusing on the genomic evolution of acute myeloid leukemia (AML) under the mentorship of Dr. Ravindra Majeti. His doctoral work led to the identification of pre-leukemic hematopoietic stem cells, which serve as the reservoir for mutation acquisition in AML. He and others have demonstrated that these pre-leukemic hematopoietic stem cells are the evolutionary ancestors to AML, they persists during remission, and may represent a novel avenue for the development of relapsed disease. Dr. Corces has continued his research at Stanford as a postdoctoral fellow under the mentorship of Dr. Howard Chang and Dr. Thomas Montine. His current research focuses on the role of the epigenome in human health and disease with a focus on cancer and neurodegenerative disease.

  • Joanne Cornbleet

    Joanne Cornbleet

    Associate Professor of Pathology at the Stanford University Medical Center, Emerita

    Current Research and Scholarly Interests As medical director of the Hematology Laboratory, my main focus is service work, including laboratory administration, bone marrow pathology, and flow cytometry interpretation. Publications arise primarily from development or evaluation of laboratory methods or collections of unusual patient cases.

  • Helio Costa

    Helio Costa

    Instructor, Pathology

    Bio Helio Costa, PhD, is a geneticist with expertise in genomics, molecular biology, molecular oncology, and bioinformatics. He is currently an Instructor within the Departments of Pathology and Biomedical Data Science at Stanford Medical School. Dr. Costa's research utilizes next-generation sequencing to develop new clinical genome and transcriptome profiling methods with the end goal of translating these tools to clinical diagnostic tests for implementation at Stanford Health Care. His research group is also interested in developing data science and machine learning methods to model and predict clinical outcomes and aid in clinical decision support. He is the founding director of the Stanford Clinical Data Science Fellowship where post-doctoral fellows engage in interdisciplinary clinical research and embed in health care workflows learning, building and deploying real-world health data solutions in the Stanford Health Care system. Additionally, he is an Attending Geneticist, and Assistant Lab Director of the Molecular Genetic Pathology Laboratory for Stanford Health Care. Dr. Costa received his BS in Genetics from University of California, Davis, his PhD in Genetics from Stanford University School of Medicine, and his ABMGG Clinical Molecular Genetics and Genomics fellowship training from Stanford University School of Medicine.

  • Tina Cowan

    Tina Cowan

    Professor of Pathology (Clinical) at the Stanford University Medical Center

    Current Research and Scholarly Interests screening and diagnosis of patients with inborn errors of metabolism, including newborn screening, development of new testing methods and genotype/phenotype correlations.

  • Gerald Crabtree

    Gerald Crabtree

    Department of Pathology Professor in Experimental Pathology and Professor of Developmental Biology

    Current Research and Scholarly Interests Chromatin regulation and its roles in human cancer and the development of the nervous system. Engineering new methods for studying and controlling chromatin in living cells.

  • John W. Day, MD, PhD

    John W. Day, MD, PhD

    Professor of Neurology, of Pediatrics (Genetics) and, by courtesy, of Pathology at the Stanford University Medical Center

    Current Research and Scholarly Interests Our Neuromuscular Division coordinates a comprehensive effort to conquer peripheral nerve and muscle disorders, including the muscular dystrophies, motor neuron disorders, neuromuscular junction abnormalities, and peripheral neuropathies. With patients and families foremost in mind, we have had success defining and combating these diseases, with research focused on identifying genetic causes, developing novel treatment, and maximizing patient function by optimizing current management.

  • Dylan Dodd

    Dylan Dodd

    Assistant Professor of Pathology and of Microbiology and Immunology

    Current Research and Scholarly Interests Harnessing the gut microbiome to treat human disease.

  • Lawrence Eng

    Lawrence Eng

    Professor (Research) of Pathology, Emeritus

    Current Research and Scholarly Interests Astrocytes make up a substantial proportion of the central nervous system (CNS) and participate in a variety of important physiologic and pathologic processes. They are characterized by vigorous response to diverse neurologic insults.

  • Edgar Engleman

    Edgar Engleman

    Professor of Pathology and of Medicine (Immunology and Rheumatology)

    Current Research and Scholarly Interests Dendritic cells, macrophages, NK cells and T cells; functional proteins and genes; immunotherapeutic approaches to cancer, autoimmune disease, neurodegenerative disease and metabolic disease.

  • Dean W. Felsher

    Dean W. Felsher

    Professor of Medicine (Oncology) and of Pathology

    Current Research and Scholarly Interests My laboratory investigates how oncogenes initiate and sustain tumorigenesis. I have developed model systems whereby I can conditionally activate oncogenes in normal human and mouse cells in tissue culture or in specific tissues of transgenic mice. In particular using the tetracycline regulatory system, I have generated a conditional model system for MYC-induced tumors. I have shown that cancers caused by the conditional over-expression of the MYC proto-oncogene regress with its inactivation.

  • Marcelo Fernandez Vina

    Marcelo Fernandez Vina

    Professor of Pathology (Research) at the Stanford University Medical Center

    Bio Marcelo Fernández-Viña, Ph.D., D (ABHI) is a Professor for the Department of Pathology at Stanford University Medical School and serves as Director of the Histocompatibility, Immunogenetics and Disease Profiling Laboratory at this institution. He has been working in the fields of Histocompatibility and Immunogenetics since 1982. He earned a degree in Biochemistry from the School of Basic Sciences in Rosario, Argentina, and his Ph.D. in Internal Medicine from the University of Buenos Aires Medical School in Argentina. Previously he held a position as a Professor in the Department of Laboratory Medicine at the University of Texas M.D. Anderson Cancer Center in Houston. He has more than 180 peer reviewed publications, many of them focusing on HLA variation in multiple world populations, identifying susceptibility and resistance factors for diseases and in the impact of HLA mismatches in allogeneic transplantation; and 59 book chapters. He served as expert Consultant for Donor Searches for NMDP and as President Elect, President and Past President of the American Society for Histocompatibility and Immunogenetics. He served as a member of the Board of Directors and the Executive Committee for the United Network for Organ Sharing. He served as Co-Chair of the Immunobiology Committee of the CIBMTR; He also served as a member of the HHS Advisory Council on Blood Stem Cell Transplantation (ACBSCT).He serves as HLA Expert Consultant for the NMDP for the HRSA contract and is a member of the Histocompatibility Advisory Group for NMDP. He is Councilor of the International Histocompatibility Workshop and a member of the WHO Nomenclature Committee for Factors of the HLA System and was Chairman of the (17th) International HLA & Immunogenetics Workshop, and current President of the International HLA & Immunogenetics Workshop. He is Section Editor of Human Immunology and an Advisory Board Member of the International Journal of Immunogenetics and Bone Marrow Transplantation.

  • Sebastian Fernandez-Pol

    Sebastian Fernandez-Pol

    Clinical Assistant Professor, Pathology

    Bio Dr. Sebastian Fernandez-Pol is an academic hematopathologist with fellowship training in hematopathology and dermatopathology. He has a particular interest in improving diagnostic accuracy for cutaneous lymphoproliferative disorders. Dr. Fernandez-Pol received his B.A. in chemistry with a concentration in biochemistry from the Washington University in St. Louis in 2003, his MD and PhD from Northwestern University in 2013, and completed his anatomic pathology and clinical pathology residency, hematopathology fellowship, and dermatopathology fellowship at Stanford University in 2019.

  • Andrew Fire

    Andrew Fire

    George D. Smith Professor in Molecular and Genetic Medicine and Professor of Pathology and of Genetics

    Current Research and Scholarly Interests We study natural cellular mechanisms for adapting to genetic change. These include systems activated during normal development and those for detecting and responding to foreign or unwanted genetic activity. Underlying these studies are questions of how a cells can distinguish information as "self" versus "nonself" or "wanted" versus "unwanted".

  • Ann Folkins

    Ann Folkins

    Assistant Professor of Pathology at the Stanford University Medical Center

    Current Research and Scholarly Interests Dr. Folkins' interest is in gynecologic and obstetric pathology, specifically in ovarian and endometrial malignancies and placental clinical-pathologic disorders.

  • Steven Foung

    Steven Foung

    Professor of Pathology

    Current Research and Scholarly Interests Our research focus is define correlates of protection against hepatitis C virus and other viral pathogens. Detailed characterization of broadly neutralizing human or nonhuman primate monoclonal antibodies against these agents will create high-resolution, functional maps of linear and nonlinear epitopes comprising the major binding sites of both isolate-specific and broadly neutralizing antibodies for rational vaccine design.

  • Susan Galel

    Susan Galel

    Associate Professor of Pathology at the Stanford University Medical Center, Emerita

    Current Research and Scholarly Interests Transfusion-transmitted infections and donor screening for infectious diseases. National policies for blood banks. Enhancement of transfusion safety and effectiveness, with a focus on quality assurance in blood banking and transfusion therapy; transfusion medicine education; pediatric and adult transfusion therapy.

  • Stephen J. Galli, MD

    Stephen J. Galli, MD

    The Mary Hewitt Loveless, M.D. Professor in the School of Medicine and Professor of Pathology and of Microbiology and Immunology

    Current Research and Scholarly Interests The goals of Dr. Galli's laboratory are to understand the regulation of mast cell and basophil development and function, and to develop and use genetic approaches to elucidate the roles of these cells in health and disease. We study both the roles of mast cells, basophils, and IgE in normal physiology and host defense, e.g., in responses to parasites and in enhancing resistance to venoms, and also their roles in pathology, e.g., anaphylaxis, food allergy, and asthma, both in mice and humans.

  • Sharon Markham Geaghan

    Sharon Markham Geaghan

    Associate Professor of Pathology at the Stanford University Medical Center, Emerita

    Current Research and Scholarly Interests Pediatric Hematopathology, Pediatric Laboratory Medicine and Pathology

Footer Links:

Stanford Medicine Resources: